Description
GHRP-6 and Ipamorelin are synthetic research peptides commonly used together in experimental models to investigate growth hormone axis regulation and pituitary receptor signaling. GHRP-6 is a hexapeptide growth hormone secretagogue that activates the growth hormone secretagogue receptor (GHS-R1a), engaging Gq/PLC-dependent calcium signaling pathways involved in GH release and hypothalamic–pituitary feedback mechanisms. Ipamorelin is a selective pentapeptide GHS-R1a agonist that promotes GH secretion through calcium-mediated signaling while exhibiting minimal interaction with other pituitary hormone systems in preclinical research. The combined use of GHRP-6 and Ipamorelin enables investigation of complementary GHS-R1a signaling dynamics, receptor pharmacology, and somatotropic pathway modulation.
For research use only. Not for human consumption.
References:
Bowers CY et al., Ann NY Acad Sci, 1998 865:244–249
Smith RG et al., Science, 1997 275(5304):1261–1264
Svensson J et al., J Endocrinol Invest, 1998 21(9):692–699
Reviews
There are no reviews yet.